Purdue Pharma Investigated for Opioid Deception

Oct 26, 2017

Reuters

Purdue Pharma has become the subject of a U.S. investigation related to its painkiller OxyContin as the company fights a number of lawsuits regarding its responsibility for contributing to the country's opioid epidemic, according to a Reuters article.

Stamford, Connecticut-based Purdue said it was cooperating with an investigation by the U.S. Attorney’s Office in Connecticut. “Purdue is committed to being part of the solution to our nation’s opioid crisis and has been cooperating with the U.S. Attorney’s investigation,” Purdue said.

Most lawsuits have accused Purdue of deceptive marketing of OxyContin and convincing doctors and patients that its drugs had a low-risk of addiction and were effective for treating chronic pain.

Read the full story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments